Form 8-K - Current report:
SEC Accession No. 0000950170-24-115955
Filing Date
2024-10-21
Accepted
2024-10-21 16:19:21
Documents
11
Period of Report
2024-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20241016.htm   iXBRL 8-K 47713
  Complete submission text file 0000950170-24-115955.txt   204456

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20241016.xsd EX-101.SCH 49101
13 EXTRACTED XBRL INSTANCE DOCUMENT revb-20241016_htm.xml XML 6943
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 241383703
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)